Pharma-Bio Serv, Inc. 8-K

What Happened

• Pharma‑Bio Serv, Inc. announced its results of operations for the fiscal year ended October 31, 2025 and furnished a press release on January 29, 2026. The company filed an 8-K (Item 2.02) to disclose the announcement and furnished the press release as Exhibit 99.1.

Key Details

• Date of announcement: January 29, 2026.
• Reporting period: results cover the year ended October 31, 2025.
• The press release with the results was furnished as Exhibit 99.1 to the 8-K.
• The 8-K treatment indicates the release was "furnished" (information provided to the SEC), not "filed" (which has different disclosure liabilities).

Why It Matters

• This 8‑K signals that Pharma‑Bio Serv has published its annual operating results (earnings/revenue and other financial metrics) for FY2025; investors should read the attached press release for specific figures such as revenue, net income, and cash flow.
• Because the filing supplies the company’s most recent operating results, it can affect investor assessment of performance and valuation; review management commentary in the release for context on trends, guidance, or material changes.